CellRenew PRO Defined
CellRenew PRO contains Hydrolyzed Collagen Type II, combined with OptiMSM (a patented bioavailable form of dietary sulfur), and Vitamin C.
CellRenew PRO provides multi-dimensional nutritional components vital for repairing connective soft tissue (joints, skin, cardiovascular, etc.). Naturally-occurring nutritional co-factors (Hyaluronic Acid, Chondroitin Sulfate, and other collagen proteins), combined with vitamin C and methylsulfonylmethane (a source of dietary sulfur, an essential mineral) offers the most potent defense against joint aging due to overuse, abuse, injury, and the normal stresses of Time and gravity on weight-bearing joints.
Each serving of CellRenew PRO includes the following:
Since 1997, Applied Health has supplied discriminating customers and doctors who accept no compromises when choosing nutritional supplements.
CellRenew PRO is the newest step in our commitment to only providing the highest-performing joint support products relied on by those who demand the very best care for their hard working joints.
That means, folks like you...
If you believe a primary principle of maintaining your youth is to continue enjoying your favorite activities, then you know the vital importance of caring for your joints.
Whether you are an aging athlete, a committed weekend warrior, or a Late-Bloomer Baby Boomer who is tackling your bucket list with renewed enthusiasm, we make CellRenew PRO for you.
Don't stop doing your favorite sports and hobbies because of sore joints... Instead, stop relying on inferior joint products, and let us prove the CellRenew PRO effect.
We guarantee, you will feel the difference.
Never Settle for Less.
|Serving Size: 4 capsules
Servings per Container: 30
|Amount Per Serving||% Daily Value|
(as L-ascorbic acid USP))
|BioCell Hydrolyzed Collagen II
(Chicken Collagen Type II)
|* Daily value not established|
|4 capsules each morning, on an empty stomach.. For best results, wait at least 20 minutes before consuming any food or other drink, allowing time for the CellRenew to digest and get into the bloodstream.|
CellRenew contains Hydrolyzed Collagen Type II derived from 100% pure chicken sternal cartilage. As an abundant source of naturally-occurring Hyaluronic Acid and Chondroitin Sulfates, Collagen Type II is easily absorbed to restore joint and cartilage health. CellRenew is produced in the United States through a patented process to deliver the highest-quality standards for safe, effective supplementation.Overview
Collagen Type II:
1 Garcia G, Komagata Y, Slavin A, Maron R, Weiner H. Suppression of collagen-induced arthritis by oral or nasal administration of type II collagen. J of Autoimmunity. 1999; 13(3): 315-324.
2 Caoa H, Xub S, Gec H, Xua F. Molecular characterisation of type II collagen from chick sternal cartilage and its anti-rheumatoid arthritis activity. Food and Agricul Immuno. 2013 Jan 9.
3 Su Z, Shotorbani SS, Jiang X, et al. A method of experimental rheumatoid arthritis induction using collagen type II isolated from chicken sternal cartilage. Mol Med Rep. 2013 Jul;8(1):113-7.
4 Trentham DE, Dynesius-Trentham RA, Orav EJ, Combitchi D. Effects of oral administration of type II collagen on rheumatoid arthritis. Science. 1993; 261(5129):1727-1730.
5 Ausar S, Beltramo D, Castagna L, Quintana S, et al. Treatment of rheumatoid arthritis by oral administration of bovine tracheal type II collagen. Rheumat Intern. 2001; 20(4):138-144.
6 Bagchi D, Misner B, Bagchi M, Kothari SC, et al. Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration. Int J Clin Pharmacol Res. 2002; 22(3-4):101-110.
7 Barnett M, Combitchi D, Trentham D. A pilot trial of oral type II collagen in the treatment of juvenile rheumatoid arthritis. Arthritis Rheum. 1996; 39:623-628.
8 Myers LK, Higgins GC, Finkel TH, Reed AM, et al. Juvenile arthritis and autoimmunity to type II collagen. Arthritis & Rheum. 2001; 44(8):1775-1781.
9 Tong T, Zhao W, Wu YQ, et al. Chicken type II collagen induced immune balance of main subtype of helper T cells in mesenteric lymph node lymphocytes in rats with collagen-induced arthritis. Inflamm Res. 2010 May;59(5):369-77.
10 Iovu M, Dumais G, Du Souich P. Anti-inflammatory activity of chondroitin sulfate. Osteoarthritis Cartilage. 2008 Jul 28.
11 Jomphe C, Gabriac M, Hale TM, et al. Chondroitin sulfate inhibits the nuclear translocation of nuclear factor-kappaB in interleukin-1beta-stimulated chondrocytes. Basic Clin Pharmacol Toxicol. 2008; 102(1):59-65.
12 Uebelhart D, Thonar EJ, Delmas PD, et al. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study. Osteoarthritis Cartilage. 1998; 6(A):39-46.
13 Uebelhart D, Malaise M, Marcolongo R, et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthritis Cartilage. 2004; 12(4):269-276.
14 Lippiello L. Glucosamine and chondroitin sulfate: biological response modifiers of chondrocytes under simulated conditions of joint stress. Osteoarthritis Cartilage. 2003; 11(5):335-342.
15 Ghersetich I, Lotti T. Hyaluronic acid in cutaneous intrinsic aging. Int J Dermatol, 1994; 33:119-122.
16 Ghosh P. The role of hyaluronic acid (hyaluronan) in health and disease: interactions with cells, cartilage and components of synovial fluid. Clin and Exper Rheumat. 1994; 12:75-82.
17 Karatosun V, Unver B, Ozden A, Ozay Z, Gunal I. Intra-articular hyaluronic acid compared to exercise therapy in osteoarthritis of the ankle. A prospective randomized trial with long-term follow-up. Clin Exp Rheumatol. 2008; 26(2):288-294.
18 Zhou PH, Liu SQ, Peng H. The effect of hyaluronic acid on IL-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis. J Orthop Res. 2008 Jun 3.
19 Ialenti A, Di Rosa M. Hyaluronic acid modulates acute and chronic inflammation. Inflammation Research. 1994; 43(1-2):44-47.
20 Pomarede N. Hyaluronic Acid. Ann Dermatol Venereol. 2008; 135(1-2):1S35-1S38.
21 Meyer LJ, Stern,R. Age-dependent changes of hyaluronan in human skin. J Invest Dermatol. 1994; 102:385-389.